OOIR: Observatory of International Research

Papers

(The H4-Index of Gut Microbes is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	220
Effect of diet on the evolution of gut commensal bacteria	193
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	188
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	184
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	146
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	145
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	132
3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain fatty acid biosyn	106
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	105
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	100
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	95
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	89
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	88
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	87
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	84
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	82
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	78
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	77
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	76
Modeling spatial interaction networks of the gut microbiota	74
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	74
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	73
Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	70
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	70
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	70

Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	69
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	67
Intestinal bacteria and colorectal cancer: etiology and treatment	67
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	65
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	65
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance	65
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	65
High throughput genome scale modeling predicts microbial vitamin requirements contribute to gut microbiome community structure	64
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy	64
The Fe-S cluster biosynthesis in Enterococcus faecium is essential for anaerobic growth and gastrointestinal colonization	64
The microbiota and the host organism switch between cooperation and competition based on dietary iron levels	63
Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis	62
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	60
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease	60
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody	58
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents	57
Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection	56
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation	56
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	56
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC	55
Comparison of gnotobiotic communities reveals milk-adapted metabolic functions and unexpected amino acid metabolism by the pre-weaning microbiome	55
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential	55
The crystal structure of the toxin EspC from enteropathogenic Escherichia coli reveals the mechanism that governs host cell entry and cytotoxicity	55
Citrobacter rodentium possesses a functional type II secretion system necessary for successful host infection	55
Regulation of flagellar motility and biosynthesis in enterohemorrhagic Escherichia coli O157:H7	54
Akkermansia in the gastrointestinal tract as a modifier of human health	53
Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer	53
Communication between the gut microbiota and peripheral nervous system in health and chronic disease	52
Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk	52
Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation	52
Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria	52
Maternal milk fat globule membrane enriched gut L. murinus and circulating SCFAs to improve placental efficiency and fetal development in intrauterine growth restricted	52